ERBB2 and breast carcinoma: Azahar Ali et al. designed a femtomolar sensitivity and high-selectivity microfluidic immunosensor for real-time detection of epidermal growth factor receptor 2 (EGFR2 or ErbB2) proteins to quantify breast cancer biomarkers.